ConductScience.org, home

Paper3208445

Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.

Böttiger B and 6 others. Clin Exp Immunol, 1988. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I. Papers, record 3208445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3208445

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Böttiger BB
2Ljunggren KK
3Karlsson AA
4Krohn KK
5Fenyö EME M
6Jondal MM
7Biberfeld GG

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
Antibody-Dependent Cell CytotoxicityMajor topic
HIV AntibodiesMajor topic
HIV-1Major topic
AIDS-Related Complex
HIV Seropositivity
Humans

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12437327Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.J Virol1987https://conductscience.org/library/papers/2437327PubMed
23474300Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus.J Infect Dis1987https://conductscience.org/library/papers/3474300PubMed
32431482HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.Science1986https://conductscience.org/library/papers/2431482PubMed
42431324Variable and conserved neutralization antigens of human immunodeficiency virus.Nature1986https://conductscience.org/library/papers/2431324PubMed
53014647Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.Science1986https://conductscience.org/library/papers/3014647PubMed
62989707HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.Nature1985https://conductscience.org/library/papers/2989707PubMed
72989706Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.Nature1985https://conductscience.org/library/papers/2989706PubMed
83257224Characterization and differentiation of CD4-, CD8- thymocytes sorted with the Ly-24 marker.J Immunol1988https://conductscience.org/library/papers/3257224PubMed
92445825Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro.J Immunol Methods1987https://conductscience.org/library/papers/2445825PubMed
103498755Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.J Immunol1987https://conductscience.org/library/papers/3498755PubMed
113477567Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells.J Virol Methods1987https://conductscience.org/library/papers/3477567PubMed
123652531Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.Clin Exp Immunol1987https://conductscience.org/library/papers/3652531PubMed
133650100Neutralizing antibodies and the course of HIV-induced disease.AIDS Res Hum Retroviruses1987https://conductscience.org/library/papers/3650100PubMed
142441727Characterization of serum neutralization response to the human immunodeficiency virus (HIV).AIDS Res Hum Retroviruses1987https://conductscience.org/library/papers/2441727PubMed
153040053A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB.AIDS Res Hum Retroviruses1987https://conductscience.org/library/papers/3040053PubMed
163475581Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.Nature1987https://conductscience.org/library/papers/3475581PubMed
173466790Induction of anti-HIV neutralizing antibodies by synthetic peptides.EMBO J1986https://conductscience.org/library/papers/3466790PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
22719248HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.PLoS Pathog2012https://conductscience.org/library/papers/22719248PubMed
20597163A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity.AIDS2010https://conductscience.org/library/papers/20597163PubMed
14632739The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression.Clin Exp Immunol2003https://conductscience.org/library/papers/14632739PubMed
12037078Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.J Clin Microbiol2002https://conductscience.org/library/papers/12037078PubMed
10473524Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.Clin Diagn Lab Immunol1999https://conductscience.org/library/papers/10473524PubMed
8464405Pathogenesis of human immunodeficiency virus infection.Microbiol Rev1993https://conductscience.org/library/papers/8464405PubMed
2746734Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.J Virol1989https://conductscience.org/library/papers/2746734PubMed
1916888Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.Immunology1991https://conductscience.org/library/papers/1916888PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3208445

GET https://conductscience.org/api/papers/v1/3208445/authors